Street research for Merrimack Pharmaceuticals, which uses its Network Biology system to discover and develop cancer treatments, is expected to be released on 5/8/12. On 3/28/12, the company raised $100.1 million by offering 14,300,000 shares at $7.00. J.P. Morgan acted as the lead manager on the deal.
